Zacks Research Has Negative Forecast for MTD Q1 Earnings

Mettler-Toledo International Inc. (NYSE:MTD) – Research analysts at Zacks Research cut their Q1 2025 earnings estimates for Mettler-Toledo International in a note issued to investors on Thursday, February 27th. Zacks Research analyst R. Department now expects that the medical instruments supplier will post earnings per share of $7.94 for the quarter, down from their previous estimate of $8.42. The consensus estimate for Mettler-Toledo International’s current full-year earnings is $42.71 per share. Zacks Research also issued estimates for Mettler-Toledo International’s Q2 2025 earnings at $10.18 EPS, Q4 2025 earnings at $13.44 EPS, Q3 2026 earnings at $12.13 EPS, FY2026 earnings at $46.73 EPS and FY2027 earnings at $55.22 EPS.

Mettler-Toledo International (NYSE:MTD) last issued its earnings results on Thursday, February 13th. The medical instruments supplier reported $12.41 earnings per share (EPS) for the quarter, topping the consensus estimate of $11.76 by $0.65. Mettler-Toledo International had a negative return on equity of 591.54% and a net margin of 22.29%.

Several other research analysts have also commented on the company. Robert W. Baird lifted their price target on Mettler-Toledo International from $1,362.00 to $1,369.00 and gave the stock a “neutral” rating in a research report on Monday, February 10th. Citigroup dropped their price objective on shares of Mettler-Toledo International from $1,450.00 to $1,400.00 and set a “neutral” rating for the company in a research note on Tuesday. Evercore ISI raised their price objective on shares of Mettler-Toledo International from $1,450.00 to $1,475.00 and gave the stock an “outperform” rating in a research note on Monday, February 10th. Wolfe Research began coverage on Mettler-Toledo International in a report on Friday, December 13th. They issued a “peer perform” rating on the stock. Finally, Wells Fargo & Company boosted their price objective on Mettler-Toledo International from $1,350.00 to $1,400.00 and gave the company an “equal weight” rating in a report on Monday, February 10th. One investment analyst has rated the stock with a sell rating, six have assigned a hold rating and three have given a buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus price target of $1,380.50.

Mettler-Toledo International Stock Performance

NYSE MTD opened at $1,242.44 on Monday. The stock has a 50 day moving average price of $1,291.82 and a 200-day moving average price of $1,326.68. Mettler-Toledo International has a one year low of $1,142.91 and a one year high of $1,546.93. The company has a market capitalization of $25.99 billion, a P/E ratio of 30.65, a P/E/G ratio of 3.30 and a beta of 1.13.

Insider Buying and Selling

In other Mettler-Toledo International news, insider Gerry Keller sold 600 shares of the business’s stock in a transaction that occurred on Monday, February 10th. The shares were sold at an average price of $1,351.34, for a total transaction of $810,804.00. Following the sale, the insider now owns 6 shares of the company’s stock, valued at approximately $8,108.04. The trade was a 99.01 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Christian Magloth sold 790 shares of the firm’s stock in a transaction on Monday, February 24th. The stock was sold at an average price of $1,313.69, for a total transaction of $1,037,815.10. Following the completion of the transaction, the insider now directly owns 734 shares of the company’s stock, valued at approximately $964,248.46. This represents a 51.84 % decrease in their position. The disclosure for this sale can be found here. 1.94% of the stock is owned by insiders.

Institutional Trading of Mettler-Toledo International

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the company. Farther Finance Advisors LLC lifted its holdings in shares of Mettler-Toledo International by 14.3% during the fourth quarter. Farther Finance Advisors LLC now owns 64 shares of the medical instruments supplier’s stock worth $78,000 after purchasing an additional 8 shares during the period. Huntington National Bank raised its holdings in shares of Mettler-Toledo International by 20.0% during the third quarter. Huntington National Bank now owns 54 shares of the medical instruments supplier’s stock worth $81,000 after purchasing an additional 9 shares during the last quarter. Townsquare Capital LLC lifted its position in Mettler-Toledo International by 2.0% during the third quarter. Townsquare Capital LLC now owns 462 shares of the medical instruments supplier’s stock valued at $693,000 after purchasing an additional 9 shares during the period. M3 Advisory Group LLC boosted its holdings in Mettler-Toledo International by 5.8% in the fourth quarter. M3 Advisory Group LLC now owns 165 shares of the medical instruments supplier’s stock valued at $202,000 after purchasing an additional 9 shares during the last quarter. Finally, Apollon Wealth Management LLC boosted its holdings in Mettler-Toledo International by 2.5% in the fourth quarter. Apollon Wealth Management LLC now owns 368 shares of the medical instruments supplier’s stock valued at $451,000 after purchasing an additional 9 shares during the last quarter. Institutional investors and hedge funds own 95.07% of the company’s stock.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.